The DOI matches its Crossref record; 158 of the 159 references it cites were found in a registry or an index.
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Abstract
Tissue hypoxia results from an inadequate supply of oxygen (O(2)) that compromises biologic functions. Evidence from experimental and clinical studies increasingly points to a fundamental role for hypoxia in solid tumors. Hypoxia in tumors is primarily a pathophysiologic consequence of structurally and functionally disturbed microcirculation and the deterioration of diffusion conditions. Tumor hypoxia appears to be strongly associated with tumor propagation, malignant progression, and resistance to therapy, and it has thus become a central issue in tumor physiology and cancer treatment. Biochemists and clinicians (as well as physiologists) define hypoxia differently; biochemists define it as O(2)-limited electron transport, and physiologists and clinicians define it as a state of reduced O(2) availability or decreased O(2) partial pressure that restricts or even abolishes functions of organs, tissues, or cells. Because malignant tumors no longer execute functions necessary for homeostasis (such as the production of adequate amounts of adenosine triphosphate), the physiology-based definitions of the term "hypoxia" are not necessarily valid for malignant tumors. Instead, alternative definitions based on clinical, biologic, and molecular effects that are observed at O(2) partial pressures below a critical level have to be applied.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
Radiobiology for the Radiologist.
(1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-80-3-438_1 · Cited by 3,498
(1989) · PubMed · Cited by 3,343
Self-citationHypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300
Gray, L. H., Conger, A. D., Ebert, M., Hornsey, S., & Scott, O. C. A. (1953) · The British Journal of Radiology · doi:10.1259/0007-1285-26-312-638 · Cited by 2,158
Holmgren, L., O’Reilly, M. S., & Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0295-149 · Cited by 1,891
HIF-1: mediator of physiological and pathophysiological responses to hypoxia
Semenza, G. L. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.4.1474 · Cited by 1,822
Höckel, M., Schlenger, K., Aral, B., Mitze, M., Schäffer, U., & Vaupel, P. W. (1996) · PubMed · Cited by 1,727
Self-citation
Research works printed but not linked: 35
- Brown, 1998, Cancer Research, 58, 1408
- Hockel, 1996, Cancer Research, 56, 4509
- Brizel, 1996, Cancer Research, 56, 941
- Walenta, 2000, Cancer Research, 60, 916
- Hockel, 1999, Cancer Research, 59, 4525
- Kim, 1997, Cancer Research, 57, 4200
- Anthoney, 1996, Cancer Research, 56, 1374
- Vaupel, 1989, Cancer Research, 49, 6449
- Vaupel, 1987, Cancer Research, 47, 3496
- Kallinowski, 1989, Cancer Research, 49, 3759
- 1973, Advances in experimental medicine and biology, 37, 277
- Vaupel, 1991, Cancer Research, 51, 3316
- Hockel, 1991, Cancer Research, 51, 6098
- Wilson, 1992, Cancer Research, 52, 3988
- 1996, BRITISH JOURNAL OF CANCER, 74, S226
- Valk, 1992, Journal of Nuclear Medicine, 33, 2133
- Groshar, 1993, Journal of Nuclear Medicine, 34, 885
- Lord, 1993, Cancer Research, 53, 5721
- Evans, 1996, Cancer Research, 56, 405
- Riva, 1998, Anticancer Research, 18, 4729
- Prehn, 1991, Cancer Research, 51, 2
- Ausserer, 1994, Molecular and Cellular Biology, 14, 5032, 10.1128/mcb.14.8.5032 · DOI
- Hartmann, 1999, Cancer Research, 59, 1578
- Koong, 1994, Cancer Research, 54, 1425
- Henderson, 1987, Cancer Research, 47, 3110
- Mitchell, 1985, Cancer Research, 45, 2008
- Reynolds, 1996, Cancer Research, 56, 5754
- Stoler, 1992, Cancer Research, 52, 4372
- Russo, 1995, Cancer Research, 55, 1122
- Teicher, 1990, Cancer Research, 50, 3339
- Teicher, 1981, Cancer Research, 41, 73
- Moan, 1985, Cancer Research, 45, 1608
- 1981, Bibliotheca anatomica, 20, 628
- 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 46, S107
- 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 48, S162
Cited by
Sorted by citations
Items 901–1,000 of 1,008
PAI‐1, CAIX, and VEGFA expressions as prognosis markers in oral squamous cell carcinoma
Peterle, G. T., Maia, L. L., Trivilin, L. O., de Oliveira, M. M., dos Santos, J. G., Mendes, S. O., Stur, E., Agostini, L. P., Rocha, L. A., Moysés, R. A., et al. (2018) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12721 · Cited by 47
Perfluorocarbon nanodroplets can reoxygenate hypoxic tumors in vivo without carbogen breathing
Xiang, Y., Bernards, N., Hoang, B., Zheng, J., & Matsuura, N. (2019) · Nanotheranostics · doi:10.7150/ntno.29908 · Cited by 46
Real-time measurement of tumour hypoxia using an implantable microfabricated oxygen sensor
Marland, J. R. K., Gray, M., Dunare, C. C., Blair, E. O., Tsiamis, A., Sullivan, P. J., González‐Fernández, E., Greenhalgh, S. N., Gregson, R., Clutton, R. E., et al. (2020) · Sensing and Bio-Sensing Research · doi:10.1016/j.sbsr.2020.100375 · Cited by 46
Gilson, R. C., Black, K. C. L., Lane, D. D., & Achilefu, S. A. (2017) · Angewandte Chemie · doi:10.1002/ange.201704458 · Cited by 46
Temporal Heterogeneity in Blood Supply in Human Tumor Xenografts
Brurberg, K. G., Gaustad, J., Mollatt, C., & Rofstad, E. K. (2008) · Neoplasia · doi:10.1593/neo.08388 · Cited by 46
Wang, R.-X., Liu, H., XU, L., Zhang, H., & Zhou, R. (2015) · Oncology Reports · doi:10.3892/or.2015.4238 · Cited by 46
Gene Expression Profile of B16(F10) Murine Melanoma Cells Exposed to Hypoxic Conditions In Vitro
Olbryt, M., Jarząb, M., Jazowiecka-Rakus, J., Simek, K., Szala, S., & Sochanik, A. (2006) · Gene Expression · doi:10.3727/000000006783991818 · Cited by 45
Epigenetics in radiotherapy: Where are we heading?
Smits, K. M., Melotte, V., Niessen, H. E. C., Dubois, L. J., Oberije, C., Troost, E. G. C., Starmans, M. H. W., Boutros, P. C., Vooijs, M., van Engeland, M., et al. (2014) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2014.05.001 · Cited by 46
Campo, L., Turley, H., Han, C., Pezzella, F., Gatter, K. C., Harris, A. L., & Fox, S. B. (2005) · The Journal of Pathology · doi:10.1002/path.1740 · Cited by 46
Hypoxia-induced dedifferentiation in neuroblastoma cells
Jögi, A., Øra, I., Nilsson, H., Poellinger, L., Axelson, H., & Påhlman, S. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00095-8 · Cited by 46
Amir, S., Golan, M., & Mabjeesh, N. J. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0497 · Cited by 47
Huang, M., Yang, L., Peng, X., Wei, S., Fan, Q., Yang, S., Li, X., Li, B., Jin, H., Wu, B., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01698-5 · Cited by 54
Hypoxic condition and prognosis in oral squamous cell carcinoma.
de Lima, P. O., Jorge, C. C., Oliveira, D. T., & Pereira, M. C. (2014) · PubMed · Cited by 44
Predictive Modeling of In Vivo Response to Gemcitabine in Pancreatic Cancer
Lee, J. J., Huang, J. S., England, C. G., McNally, L. R., & Frieboes, H. B. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003231 · Cited by 44
Pal, A., Srivastava, T., Sharma, M. K., Mehndiratta, M., Das, P., Sinha, S., & Chattopadhyay, P. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00792.x · Cited by 45
Non-receptor protein-tyrosine kinases as molecular targets for antiangiogenic therapy (Review)
Kanda, S., Miyata, Y., Kanetake, H., & Smithgall, T. E. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.20.1.113 · Cited by 46
Koperek, O., Bergner, O., Pichlhöfer, B., Oberndorfer, F., Hainfellner, J. A., Kaserer, K., Horvat, R., Harris, A. L., Niederle, B., & Birner, P. (2011) · The Journal of Pathology · doi:10.1002/path.2926 · Cited by 45
Mao, Z.-J., Tang, Q., Zhang, C., Qin, Z., Pang, B., Wei, P.-K., Liu, B., & Chou, Y.-N. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13056521 · Cited by 45
Tumor Hypoxia Regulates Forkhead Box C1 to Promote Lung Cancer Progression
Lin, Y., Shyu, W., Chang, C., Wang, C.-C., Wu, C., Lee, H., Chen, L., & Hsieh, C. (2017) · Theranostics · doi:10.7150/thno.17895 · Cited by 45
Pulsed Electron Paramagnetic Resonance Imaging: Applications in the Studies of Tumor Physiology
Kishimoto, S., Matsumoto, K., Saito, K., Enomoto, A., Matsumoto, S., Mitchell, J. B., Devasahayam, N., & Krishna, M. C. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7391 · Cited by 45
Zhang, H., Yang, Q., Lian, X., Jiang, P., & Cui, J. (2019) · Medical Science Monitor · doi:10.12659/msm.916886 · Cited by 45
Gan, E. S., & Ooi, E. E. (2020) · Virology Journal · doi:10.1186/s12985-020-01374-2 · Cited by 46
Ou‐Yang, F., Hou, M., Yang, S., Huang, S.-C., & Lee, W. (2009) · PubMed · Cited by 45
Inhibitors of angiogenesis and cancer-related receptor tyrosine kinases
Mazitschek, R., & Giannis, A. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.06.009 · Cited by 44
Zhao, D., Constantinescu, A., Hahn, E. W., et al. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02822-5 · Cited by 45
ATF4-induced warburg metabolism drives over-proliferation in Drosophila
Sorge, S., Theelke, J., Yildirim, K., Hertenstein, H., McMullen, E., Müller, S., Altbürger, C., Schirmeier, S., & Lohmann, I. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107659 · Cited by 44
Radiocurability Is Associated with Interstitial Fluid Pressure in Human Tumor Xenografts
Rofstad, E. K., Gaustad, J., Brurberg, K. G., Mathiesen, B. S., Galappathi, K., & Simonsen, T. G. (2009) · Neoplasia · doi:10.1593/neo.91152 · Cited by 44
Novel Model for Basaloid Triple-negative Breast Cancer: Behavior In Vivo and Response to Therapy
Volk-Draper, L. D., Rajput, S., Hall, K. L., Wilber, A. C., & Rana, S. (2012) · Neoplasia · doi:10.1593/neo.12956 · Cited by 44
Bollineni, V. R., Wiegman, E. M., Pruim, J., Groen, H. J. M., & Langendijk, J. A. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.04.003 · Cited by 44
Snail1 Mediates Hypoxia-Induced Melanoma Progression
Liu, S., Kumar, S. M., Martin, J. S., Yang, R., & Xu, X. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.08.038 · Cited by 44
Molecular Imaging of Hypoxia: Strategies for Probe Design and Application
Apte, S., Chin, F. T., & Graves, E. E. (2011) · Current Organic Synthesis · doi:10.2174/157017911796117179 · Cited by 44
Mouriaux, F., Sanschagrin, F., Diorio, C., Landreville, S., Comoz, F., Petit, E., Bernaudin, M., Rousseau, A. P., Bergeron, D., & Morcos, M. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-13345 · Cited by 48
Tumour, Oxidative Stress and Host T Cell Response: Cementing the Dominance
Bhattacharyya, S., & Saha, J. (2015) · Scandinavian Journal of Immunology · doi:10.1111/sji.12350 · Cited by 44
Kasinskas, R. W., Venkatasubramanian, R., & Forbes, N. S. (2014) · Integrative Biology · doi:10.1039/c4ib00001c · Cited by 44
Hajeri, V. A., Trejo, J., & Padilla, P. A. (2005) · BMC Cell Biology · doi:10.1186/1471-2121-6-47 · Cited by 44
Insights into the Regulatory Role of Non-coding RNAs in Cancer Metabolism
Beltrán‐Anaya, F. O., Cedro‐Tanda, A., Hidalgo‐Miranda, A., & Romero-Cordoba, S. L. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00342 · Cited by 44
Gulzar, A., Wang, Z., He, F., et al. (2020) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.0c00170 · Cited by 44
Impact of hypoxia on cervical cancer outcomes
Datta, A., West, C., O’Connor, J. P. B., Choudhury, A., & Hoskin, P. (2021) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2021-002806 · Cited by 44
Natural compounds and the hypoxia-inducible factor (HIF) signalling pathway
Manolescu, B. N., Oprea, E., Buşu, C., & Cercasov, C. (2009) · Biochimie · doi:10.1016/j.biochi.2009.08.005 · Cited by 46
Graff, B. A., Benjaminsen, I. C., Brurberg, K. G., et al. (2005) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20265 · Cited by 44
The immunohistochemical assessment of hypoxia, vascularity and proliferation in bladder carcinoma
Hoskin, P., Sibtain, A., Daley, F. M., et al. (2004) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2004.03.017 · Cited by 44
Where are we with imaging oxygenation in human tumours?
Padhani, A. R. (2005) · Cancer Imaging · doi:10.1102/1470-7330.2005.0103 · Cited by 44
Bhatt, A., Mahon, B. P., Cruzeiro, V. W. D., et al. (2016) · ChemBioChem · doi:10.1002/cbic.201600513 · Cited by 43
Menilli, L., Milani, C., Reddi, E., & Moret, F. (2022) · Cancers · doi:10.3390/cancers14184462 · Cited by 45
Ma, Y., & Fenton, O. S. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c02584 · Cited by 44
Fluorescence microscopy imaging of mitochondrial metabolism in cancer cells
Gooz, M. B., & Maldonado, E. N. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1152553 · Cited by 44
Zhang, Y., Zhang, B., Lv, C., Zhang, N., Xing, K., Wang, Z., Lv, R., Yu, M., Xu, C., & Wang, Y. (2023) · Theranostics · doi:10.7150/thno.81407 · Cited by 45
Nagamine, Y. (2008) · Thrombosis and Haemostasis · doi:10.1160/th08-05-0294 · Cited by 43
Milbank, J. B. J., Stevenson, R. J., Ware, D. C., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9008746 · Cited by 43
Takes, R. P., Rinaldo, A., Rodrigo, J. P., et al. (2008) · Head & Neck · doi:10.1002/hed.20759 · Cited by 43
A miR-297/hypoxia/DGK-α axis regulating glioblastoma survival
Kefas, B. A., Floyd, D. H., Comeau, L., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not118 · Cited by 43
Tumor cell response to bevacizumab single agent therapy in vitro
Hein, M., & Graver, S. (2013) · Cancer Cell International · doi:10.1186/1475-2867-13-94 · Cited by 42
Bonekamp, D., Mouridsen, K., Radbruch, A., et al. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16630322 · Cited by 43
Hayashi, K., Maruhashi, T., Nakamura, M., Sakamoto, W., & Yogo, T. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201603394 · Cited by 43
Pott, L. L., Hagemann, S., Reis, H., Lorenz, K., Bracht, T., Herold, T., Skryabin, B. V., Megger, D. A., Kälsch, J., Weber, F., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14447 · Cited by 43
Emerging role of RUNX3 in the regulation of tumor microenvironment
Manandhar, S., & Lee, Y. M. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.4.033 · Cited by 43
Kazokaitė, J., Niemans, R., Dudutienė, V., Becker, H. M., Leitāns, J., Zubrienė, A., Baranauskienė, L., Gondi, G., Zeidler, R., Matulienė, J., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25508 · Cited by 44
A novel fluorescent turn-on probe for highly selective detection of nitroreductase in tumor cells
Zhu, K., Qin, T., Zhao, C., et al. (2018) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2018.08.134 · Cited by 43
Teodori, E., Braconi, L., Bua, S., Lapucci, A., Bartolucci, G., Manetti, D., Romanelli, M. N., Dei, S., Supuran, C. T., & Coronnello, M. (2020) · Molecules · doi:10.3390/molecules25071748 · Cited by 44
Hypoxia, hypoxia-inducible gene 2 (HIG2)/HILPDA, and intracellular lipolysis in cancer
Povero, D., Johnson, S. M., & Liu, J. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.06.013 · Cited by 46
Brutkiewicz, S. A., Mendonca, M. S., Stantz, K. M., Comerford, K., Bigsby, R. M., Hutchins, G. D., Goebl, M. G., & Harrington, M. A. (2007) · Luminescence · doi:10.1002/bio.953 · Cited by 45
Xu, R. X., Young, D. C., Mao, J. J. M., & Povoski, S. P. (2007) · Breast Cancer Research · doi:10.1186/bcr1837 · Cited by 43
Role of Prolactin and Vasoinhibins in the Regulation of Vascular Function in Mammary Gland
Clapp, C., Thébault, S. C., & de la Escalera, G. M. (2008) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-008-9067-7 · Cited by 43
Defining the gene expression signature of rhabdomyosarcoma by meta-analysis
Romualdi, C., Pittà, C. D., Tombolan, L., Bortoluzzi, S., Sartori, F., Rosolen, A., & Lanfranchi, G. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-287 · Cited by 43
Wang, S., Wu, X., Zhang, Y., Zhang, D., Xie, B., Pan, Z., Ouyang, K., & Peng, T. (2021) · Organic & Biomolecular Chemistry · doi:10.1039/d1ob00356a · Cited by 44
Scholten, D. J., Timmer, C. M., Peacock, J. D., Pelle, D. W., Williams, B. O., & Steensma, M. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111431 · Cited by 43
Takakusagi, Y., Matsumoto, S., Saito, K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107995 · Cited by 42
Radiotherapy for the management of locally advanced squamous cell carcinoma of the head and neck
Ko, C. J., & Citrin, D. E. (2008) · Oral Diseases · doi:10.1111/j.1601-0825.2008.01495.x · Cited by 42
Molecular Imaging of Tumor Hypoxia with Positron Emission Tomography
Kelada, O. J., & Carlson, D. J. (2014) · Radiation Research · doi:10.1667/rr13590.1 · Cited by 42
The domino effect: Role of hypoxia in malignant transformation of oral submucous fibrosis
Bajaj, S., Chaudhary, M. S., Bohra, S., Swastika, N., & Hande, A. H. (2015) · Journal of Oral and Maxillofacial Pathology · doi:10.4103/0973-029x.164519 · Cited by 42
An MRI Method To Map Tumor Hypoxia Using Red Blood Cells Loaded with a pO 2 -Responsive Gd-Agent
Gregorio, E. D., Ferrauto, G., Gianolio, E., et al. (2015) · ACS Nano · doi:10.1021/acsnano.5b02604 · Cited by 42
MiR200 and miR302: Two Big Families Influencing Stem Cell Behavior
Balzano, F., Cruciani, S., Basoli, V., Santaniello, S., Facchin, F., Ventura, C., & Maioli, M. (2018) · Molecules · doi:10.3390/molecules23020282 · Cited by 41
Lan, Y., Zhu, X., Tang, M., et al. (2020) · Nanoscale · doi:10.1039/c9nr10453d · Cited by 42
Oxygen-Sufficient Nanoplatform for Chemo-Sonodynamic Therapy of Hypoxic Tumors
Huang, B., Chen, S., Pei, W., Xu, Y., Jiang, Z., Niu, C., & Wang, L. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00358 · Cited by 42
Rahmanian, M., Seyfoori, A., Ghasemi, M., Shamsi, M., Kolahchi, A. R., Modarres, H. P., Sanati‐Nezhad, A., & Majidzadeh‐A, K. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.04.024 · Cited by 42
Ahmad, Z., Lv, S., Tang, Z., Shah, A., & Chen, X. (2015) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2015.1107707 · Cited by 42
Dorow, D. S., Cullinane, C. M., Conus, N. M., Roselt, P. D., Binns, D., McCarthy, T. J., McArthur, G. A., & Hicks, R. J. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-0039-5 · Cited by 42
NK4 gene therapy targeting HGF-Met and angiogenesis
Matsumoto, K. (2007) · Frontiers in bioscience · doi:10.2741/2813 · Cited by 42
Egeland, T. A. M., Gaustad, J., Vestvik, I. K., et al. (2006) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20852 · Cited by 42
Kelleher, D. K., Thews, O., Scherz, A. J., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601457 · Cited by 42
Self-citationTargeting the Vascular Endothelial Growth Factor Pathway in the Treatment of Human Malignancy
Tonra, J. R., & Hicklin, D. J. (2006) · Immunological Investigations · doi:10.1080/08820130600991794 · Cited by 43
Up-regulation of the hypoxia-inducible factor–1 transcriptional pathway in colorectal carcinomas
Furlan, D., Sahnane, N., Carnevali, I. W., Cerutti, R., Bertoni, F., Kwee, I., Uccella, S., Bertolini, V., Chiaravalli, A. M., & Capella, C. (2008) · Human Pathology · doi:10.1016/j.humpath.2008.02.013 · Cited by 42
Weeks, A. J., Paul, R. L., Marsden, P. K., et al. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1305-8 · Cited by 42
Guimarães, T. A., Farias, L. C., Fraga, C. A. D. C., Feltenberger, J. D., Melo, G. A., Coletta, R. D., Santos, S. H. S., de Paula, A. M. B., & Guimarães, A. L. S. (2016) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000342 · Cited by 44
Gołąb, J., Olszewska, D., Mróz, P., Kozar, K., Kamiński, R., Jalili, A., & Jakóbisiak, M. (2002) · PubMed · Cited by 42
Xiong, Y., Yong, Z., Chen, X., Deng, Q., Wang, Q., Li, S., Wang, C., Zhang, Z., Yang, X., & Li, Z. (2023) · Advanced Science · doi:10.1002/advs.202301278 · Cited by 42
Botlagunta, M., Krishnamachary, B., Vesuna, F., Winnard, P. T., Bol, G. M., Patel, A. H., & Raman, V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017563 · Cited by 41
Klein, O. J., Bhayana, B., Park, Y. J., et al. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300262x · Cited by 41
Quantitative Assessment of Heterogeneity in Tumor Metabolism Using FDG-PET
Vriens, D., Disselhorst, J. A., Oyen, W. J. G., et al. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.11.039 · Cited by 41
Mitochondria-specific Oxygen Probe Based on Iridium Complexes Bearing Triphenylphosphonium Cation
Murase, T., Yoshihara, T., & Tobita, S. (2012) · Chemistry Letters · doi:10.1246/cl.2012.262 · Cited by 41
WANG, Z., ZHANG, L., ZHANG, D., et al. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2945 · Cited by 41
Tan, Z., Wang, C., Li, X., & Guan, F. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00210 · Cited by 42
Zhao, W., Li, A., Zhang, A., Zheng, Y., & Liu, J. (2018) · ChemMedChem · doi:10.1002/cmdc.201800462 · Cited by 43
Photothermal-Controlled Generation of Alkyl Radical from Organic Nanoparticles for Tumor Treatment
Xia, R., Zheng, X., Hu, X., et al. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b18953 · Cited by 41
Hillestad, T., Hompland, T., Fjeldbo, C. S., Skingen, V. E., Salberg, U. B., Aarnes, E., Nilsen, A., Lund, K. V., Evensen, T. S., Kristensen, G. B., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0950 · Cited by 41
Alghamdi, M. A., Gumbleton, M., & Newland, B. (2021) · Biomaterials Science · doi:10.1039/d1bm00896j · Cited by 45
Cramer, T., & Vaupel, P. W. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.12.028 · Cited by 41
Self-citationElevated Serum Level of IL-23 Correlates with Expression of VEGF in Human Colorectal Carcinoma
Ljujić, B., Radosavljevic, G. D., Jovanović, I., Pavlovic, S. M., Zdravkovic, N. S., Milovanović, M., Aćimović, L., Knežević, M., Banković, D., Zdravkovic, D., et al. (2010) · Archives of Medical Research · doi:10.1016/j.arcmed.2010.02.009 · Cited by 41
Hypoxia-inducible factor 2α: a novel target in gliomas
Renfrow, J. J., Soike, M. H., Debinski, W., Ramkissoon, S. H., Mott, R. T., Frenkel, M. B., Sarkaria, J. N., Lesser, G. J., & Strowd, R. E. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0163 · Cited by 40
Schietroma, M., Carlei, F., Cecilia, E. M., Piccione, F., Bianchi, Z., & Amicucci, G. (2014) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-013-2378-z · Cited by 37
Retracted
Metadata
- Authors
- Hockel, M., & Vaupel, P.
- Affiliations
- Johannes Gutenberg University Mainz (DE)
- Corresponding author
- Vaupel, P.
- ORCID
- Vaupel, P.
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-02-21
- Volume
- 93
- Issue
- 4
- Pages
- 266-276
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2125257427
- Semantic Scholar
- 6c70b98add72efaae8670b5183983be403de59ae
- Cited by
- 2,662
- References
- 159
- Citations by year
- 2026: 46 · 2025: 65 · 2024: 93 · 2023: 134 · 2022: 110 · 2021: 139 · 2020: 149 · 2019: 120 · 2018: 110 · 2017: 148 · 2016: 143 · 2015: 123 · 2014: 114 · 2013: 104 · 2012: 114
- FWCI
- 5.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JNCI Journal of the National Cancer Institute (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- tumor hypoxia, tissue hypoxia, solid tumors, tumor microcirculation, oxygen partial pressure, tumor progression, treatment resistance, tumor physiology, oxygen diffusion
- MeSH terms
- Animals, Humans, Neoplasms, Oxygen, Predictive Value of Tests, Prognosis, Risk Factors, Cell Hypoxia, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review